Pharmacist Follow-up, a Qualitative Study of Patient Experience

NCT01131715 | Completed

• 1 other identifier: SHAN-002
• Study Type: observational
• Target: 4
• Locations: 1 country
• Sites: 1

Brief Summary

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Conditions

Patient Satisfaction; Patient Preference

Keywords

Qualitetive interview; Coronary heart disease (CHD); Patient experience; Patient perception

Outcome Measures

Primary Outcomes (1)

• Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients

  In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients' experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings. Outcomes will be presented as overall themes touched by the informants.

  3 months or 1 year

Study Arms (1)

Study group

Patients who are included in the pharmacist follow-up procedure

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients included in the study "Pharmacist follow-up of patients with CHD".

You may qualify if:

• must have met the pharmacist at least twice
• living within the area of Tromsoe city so that interviews are possible

You may not qualify if:

• none as patients are already enrolled in another study

Sponsors & Collaborators

• Hospital Pharmacy of North Norway Trust: lead
• University of Tromso: collaborator

Study Sites (1)

University of Tromsoe

Tromsø, 9037, Norway

Location

Related Publications (1)

• Garcia BH, Storli SL, Smabrekke L. A pharmacist-led follow-up program for patients with coronary heart disease in North Norway--a qualitative study exploring patient experiences. BMC Res Notes. 2014 Mar 29;7:197. doi: 10.1186/1756-0500-7-197.

  PMID: 24679131 DERIVED

Related Links

• Published article

MeSH Terms

Conditions

Patient Satisfaction; Patient Preference; Coronary Disease

Condition Hierarchy (Ancestors)

Treatment Adherence and Compliance; Health Behavior; Behavior; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases

Study Officials

• Lars Smaabrekke, PhD

  University of Tromso

  PRINCIPAL INVESTIGATOR

• Beate H Garcia, PhD

  Hospital Pharmacy of North Norway Trust

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: April 30, 2010
• First Posted: May 27, 2010
• Study Start: February 1, 2010
• Primary Completion: March 1, 2010
• Study Completion: July 1, 2012
• Last Updated: June 29, 2020

Record last verified: 2020-06

Locations

NO (1)